# AN2 Therapeutics (ANTX) — Analyst Forecast

ANTX · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/antx/forecast

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Jul 20, 2026 | Guggenheim | Initiated Coverage | Buy | $9.00 |
| May 14, 2026 | Leerink Partners | Upgraded | Market Perform → Outperform | $9.00 |
| May 5, 2025 | JMP Securities | Maintained | Market Outperform | $2.00 |
| Mar 26, 2025 | Citizens Capital Markets | Maintained | Market Outperform | $5.00 |
| Feb 25, 2025 | Citizens Capital Markets | Maintained | Market Outperform | $5.00 |
| Feb 3, 2025 | JMP Securities | Maintained | Market Outperform | $5.00 |
| Nov 19, 2024 | JMP Securities | Maintained | Market Outperform | $5.00 |
| Nov 18, 2024 | TD Cowen | Downgraded | Buy → Hold | — |
| Aug 9, 2024 | JMP Securities | Maintained | Market Outperform | $3.00 |
| Jul 3, 2024 | Leerink Partners | Upgraded | Market Perform → Outperform | — |
| May 16, 2024 | Evercore ISI Group | Maintained | In-Line | $2.00 |
| Apr 2, 2024 | JMP Securities | Upgraded | Market Perform → Market Outperform | $6.00 |
| Apr 1, 2024 | Oppenheimer | Maintained | Perform | — |
| Feb 13, 2024 | Leerink Partners | Downgraded | Outperform → Market Perform | $7.00 |
| Feb 12, 2024 | JMP Securities | Downgraded | Market Outperform → Market Perform | — |
| Feb 12, 2024 | Oppenheimer | Downgraded | Outperform → Perform | — |
| Feb 12, 2024 | Evercore ISI Group | Downgraded | Outperform → In-Line | $7.00 |
| Jan 4, 2024 | JMP Securities | Initiated Coverage | Market Outperform | $30.00 |
| Mar 30, 2023 | Oppenheimer | Maintained | Outperform | $24.00 |

## Frequently Asked Questions

### What is the latest analyst rating on ANTX?

On Jul 20, 2026, Guggenheim initiated coverage of AN2 Therapeutics at Buy with a price target of $9.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).